SAGECREST HOSPITAL GRAPEVINE — History
CCN 670265 | 3-year financial timeline | COVID resilience: 40/100
🛡️ Public data only — no PHI permitted on this instance.
$37M
Latest Revenue (FY2022)
+11.8%
Revenue CAGR (3yr)
-19.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $29M | $41M | $37M | -9.5% | +11.8% |
| Operating Expenses | $33M | $48M | $44M | -8.3% | +14.4% |
| Operating Margin | -13.6% | -17.5% | -19.0% | -8.8% | +0.0% |
| Net Income | $-4M | $-7M | $-7M | +1.6% | +0.0% |
| Licensed Beds | 45 | 22 | 20 | -9.1% | -33.3% |
| Total Patient Days | 6,490 | 936 | 858 | -8.3% | -63.6% |
| Medicare Day % | 2% | 16% | 11% | -28.2% | +115.9% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 40/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +25.0% ($29M → $37M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+11.8%
This Hospital
+7.6%
State Avg
Latest Margin
-19.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $41M | -21.7% |
| FY2024 (proj) | $44M | -24.5% |
| FY2025 (proj) | $48M | -27.2% |